Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613
Guardado Rivas, Moises O, Stuart, Shawn D, Thach, Daniel, Dahan, Michael, Shorr, Robert, Zachar, Zuzana, Bingham, Paul M
Published in PloS one (08.06.2022)
Published in PloS one (08.06.2022)
Get full text
Journal Article
Site-specific antibody conjugation of metal chelators for nuclear imaging and therapy
Ahn, Shin Hye, Thach, Daniel, Vaughn, Brett, Boros, Eszter
Published in The Journal of nuclear medicine (1978) (01.05.2019)
Get full text
Published in The Journal of nuclear medicine (1978) (01.05.2019)
Journal Article
Linear Desferrichrome-Linked Silicon–Rhodamine Antibody Conjugate Enables Targeted Multimodal Imaging of HER2 in Vitro and in Vivo
Ahn, Shin Hye, Thach, Daniel, Vaughn, Brett A, Alford, Vincent M, Preston, Alyssa N, Laughlin, Scott T, Boros, Eszter
Published in Molecular pharmaceutics (04.03.2019)
Published in Molecular pharmaceutics (04.03.2019)
Get full text
Journal Article
Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613
Moises O Guardado Rivas, Shawn D Stuart, Daniel Thach, Michael Dahan, Robert Shorr, Zuzana Zachar, Paul M Bingham
Published in PloS one (01.01.2022)
Published in PloS one (01.01.2022)
Get full text
Journal Article
APR-246 increases tumor antigenicity independent of p53
Michels, Judith, Venkatesh, Divya, Liu, Cailian, Budhu, Sadna, Zhong, Hong, George, Mariam M, Thach, Daniel, Yao, Zhong-Ke, Ouerfelli, Ouathek, Liu, Hengrui, Stockwell, Brent R, Campesato, Luis Felipe, Zamarin, Dmitriy, Zappasodi, Roberta, Wolchok, Jedd D, Merghoub, Taha
Published in Life science alliance (01.01.2024)
Published in Life science alliance (01.01.2024)
Get full text
Journal Article